Articles

10 social media events that changed healthcare in 2014

18th December 2014

10 social media events that changed healthcare in 2014Daniel Ghinn

This month, Daniel Ghinn reviews some of the key online happenings that have had an impact on healthcare over the year.The year 2014 has been incredible for social media in... Read more

Tunnah’s musings: Reviewing the health of 2014 on Google

17th December 2014

Tunnah’s musings: Reviewing the health of 2014 on GooglePaul Tunnah

As 2014 draws to a close Paul Tunnah takes a different tack on his review of the year for the pharmaceutical industry, using Google to search for his inspiration on... Read more

Early Access: the ground rules for communicating with physicians and p…

16th December 2014

Early Access: the ground rules for communicating with physicians and patientsHolly Lumgair

How should medical departments, advocacy liaison leaders and communication teams in pharma companies deal with demand for early access to investigational medicines?The last few years have seen a rapid increase... Read more

International league tables and medicines

15th December 2014

International league tables and medicinesLeela Barham

Many people love a good league table; those tables that show you the best schools and universities to study at, the best companies to work for, or even the best... Read more

News

Australia finally gives cystic fibrosis patients access to Kalydeco

18th December 2014

Australia finally gives cystic fibrosis patients access to KalydecoStaff reporter

After months of wrangling, Australia has listed Vertex' cystic fibrosis (CF) therapy Kalydeco in the Pharmaceutical Benefits Scheme, finally giving patients access to the new drug.Negotiations over pricing of Kalydeco... Read more

Google Ventures increases healthcare investment

17th December 2014

Google Ventures increases healthcare investmentStaff reporter

Google's venture capital division has embarked on a push into healthcare as it follows the lead of its parent company.The fund has directed more than a third of its investments... Read more

NICE recommends Pfizer's kidney cancer treatment Inlyta

16th December 2014

NICE recommends Pfizer's kidney cancer treatment InlytaAndrew McConaghie

Pfizer is set to gain a NICE recommendation for its renal cell carcinoma treatment Inlyta, two years after its launch.The drug is to be used as second line therapy after... Read more

Experimental Ebola blood therapy trial gets under way

15th December 2014

Experimental Ebola blood therapy trial gets under wayAndrew McConaghie

Blood taken from survivors of Ebola could help protect others who contract the deadly disease, as part of a new trial in Liberia.The Ebola convalescent plasma (ECP) clinical trial will... Read more

Audio & Video

On demand webinar: The Price is Right? -…

Slide-300x200b

 

With challenges to highly priced rare disease medicines and the Cancer Drug Fund evolving again – what is next, what are the... View more

Now on demand - real world insight into …

The Diabetes Debate

 

Now available on demand (free to access) - originally broadcast on October 29th 2014.


Non-adherence to self-management regimens in diabetes is globally... View more

On-demand webinar: Is pharma brand marke…

Kantar Health webinar


While pharma observers speculate on the death of outdated drug discovery and sales models, some critical wounds to... View more

View the conversation - Tweetchat: Manag…

Atlantis Healthcare diabetes Tweetchat


Working in partnership, Atlantis Healthcare and pharmaphorum conducted a Tweetchat focussed on the real world challenges patients face in managing... View more

White Papers

How do doctors want to engage with pharm…

How do doctors want to engage with pharma on new products?Dr Tim Ringrose

With more than 80 per cent of European doctors saying they want to stay abreast of new developments about pharmaceutical products, it is important to understand how they wish to... View info

Modelling patient behaviour to improve s…

Modelling patient behaviour to improve self-management in diabetesDr Sinéad NíMhurchadha & Jeremy Sayers

An understanding of health psychology is essential to helping patients adhere to their medication and lifestyle regimens. This report hones in on how the COM-B model of behaviour provides a... View info

"The future ain’t what it used to b…

"The future ain’t what it used to be"Paul Stuart-Kregor

Preparation is key to creating and maintaining a strong drugs pipeline. However, the statistics demonstrate that successful product commercialisation strategies are not always implemented. Products are developed for which there... View info

Healthcare Innovation: the big ideas sha…

Healthcare Innovation: the big ideas shaping the future of pharmaDavid Rowley

The transformation taking place in healthcare is challenging for everyone and adaptability is key for the pharma industry's continued success.

Long production cycles, concentration on specialist drugs with high... View info

Further News & Articles

The evolving role of patient advocates at medical congresses

Organisers of medical conferences should include patient advocates on the podium and in the audience as their dir... Read more

Articles

Merck's Keytruda shows potential in aggressive breast cancer

Merck & Co's PD-1 inhibitor Keytruda could add breast cancer to its list of uses if early-stage data are backed up i... Read more

News

Putting the case for regenerative medicine

Stem cell research always courts controversy and an application by the International Stem Cell Corporation (ISCC) fo... Read more

Articles

Bluebird's gene therapy promises thalassaemia cure

Patients with the rare genetic blood disorder beta thalassaemia have been spared the need for routine blood t... Read more

News

Imbruvica strengthens its case against blood cancers

Longer-term follow-up data on Imbruvica (ibrutimib) has shown its continued effectiveness against chronic lym... Read more

News